Latest news
Scientist Whose Research Led to Sugammadex Joins Eikon Board - Stock TitanStock Titan · Mon, 10 Aug 2026 11:30:00 GMTFMR LLC reports 9.2% Eikon Therapeutics (EIKN) ownership on amended 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:21:02 GMTTwo Eikon Therapeutics, Inc. (Nasdaq: EIKN) directors step down - Stock TitanStock Titan · Mon, 03 Aug 2026 20:40:42 GMT